Experiment shows oxidative stress and inflammation reduce in neuroblastoma models with sweet orange EO and limonene, suggesting neuroprotective effects for Parkinson's disease.
Based on these results, sweet orange EO and its main component, (+)-limonene, can be considered as neuroprotective agents and are promising candidates for complementary therapy in Parkinson's disease.
No takes yet. Share an insight, caveat, or question.
Pandur et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: